AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea
· Delayed Price · Currency is KRW 8,510.00
+60.00 (0.71%)
At close: Dec 5, 2025
AptaBio Therapeutics Revenue
AptaBio Therapeutics had revenue of 1.19B KRW in the quarter ending September 30, 2025, with 38.66% growth. This brings the company's revenue in the last twelve months to 3.44B, up 18.39% year-over-year. In the year 2024, AptaBio Therapeutics had annual revenue of 3.36B with 937.76% growth.
Revenue (ttm)
3.44B
Revenue Growth
+18.39%
P/S Ratio
69.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
237.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36B | 3.04B | 937.76% |
| Dec 31, 2023 | 323.87M | 275.52M | 569.80% |
| Dec 31, 2022 | 48.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition